Hand holding the newspaper resting on a table with a cup of coffee

Newsroom

Taxonomy Icon
Could Karyopharm’s Newly Approved Multiple Myeloma Drug Also Work In Glioblastoma?
  • July 15, 2019
  • Source: FierceBiotech
The Ivy Brain Tumor’s goal is to try to speed advances into the clinic by testing potential therapies on tumor samples taken from patients who are currently battling glioblastoma—an approach its researchers hope will shed some light on the potential of Karyopharm’s new drug in treating the disease.
Taxonomy Icon
Ivy Brain Tumor Center And Karyopharm Therapeutics Collaborate To Develop Tissue-Based Clinical Trial For Brain Cancer
  • July 11, 2019
The Ivy Brain Tumor Center at the Barrow Neurological Institute has announced a partnership with Karyopharm Therapeutics (Nasdaq:KPTI) to accelerate the treatment of brain cancer.
Taxonomy Icon
The Ivy Brain Tumor Center Takes A ‘High Risk, High Reward’ Approach To Brain Cancer Trials
  • May 14, 2019
  • Source: MedCity News
"Our philosophy is that it is as important to fail fast as it is to succeed quickly," said Nader Sanai, the director of the Ivy Brain Tumor Center at Barrow Neurological Institute.
Taxonomy Icon
Ivy Brain Tumor Center fights to end deadly brain cancer
  • April 26, 2019
  • Source: Chamber Business News
In the heart of Phoenix, a team of doctors is vigilantly working to find a cure for Glioblastoma (GBM), the deadliest form of brain cancer.
Taxonomy Icon
Fighting Brain Cancer with Phase 0 Clinical Trials: An American Hero at Barrow Neurological Institute
  • April 14, 2019
  • Source: TrialSiteNews
The Ben & Catherine Ivy Foundation has provided a $50 million grant to Ivy Brain Tumor Center —these funds are powering the Phase 0 research in an attempt to combat brain cancer.
Taxonomy Icon
Phase 0 trials ‘quickest route’ for development of glioblastoma treatments
  • April 10, 2019
  • Source: Healio | HemOnc Today
Ivy Brain Tumor Center at The Barrow Neurological Institute has launched a program that offers phase 0 trials to accelerate the drug approval process for patients with glioblastoma.
Taxonomy Icon
A Bold Approach to Identify New and Effective Therapies for Malignant Brain Tumors
  • April 8, 2019
  • Source: The Onco'Zine Brief
In this edition of The Onco’Zine Brief Peter Hofland talks with Dr. Nader Sanai an internationally-recognized neurosurgical oncologist with clinical and research expertise in the treatment of all brain tumors, including glioblastoma, the most aggressive cancer that begins within the brain.
Taxonomy Icon
New Strategies Take on the Worst Cancer–Glioblastoma
  • March 27, 2019
  • Source: Scientific American
In Bret Stetka's latest piece for the Scientific American, Dr. Nader Sanai weighs in on the challenges of treating glioblastoma and how our accelerated Phase 0/2 clinical trials are delivering new therapeutic options for patients facing the fight of their lives.
Taxonomy Icon
Gliobastoma treatment: Valley center makes brain tumor breakthrough
  • January 21, 2019
  • Source: KGUN 9
The Ivy Brain Tumor Center at Barrow Neurological Institute is taking a bold approach by using Phase 0 testing in patient clinical trials.
Taxonomy Icon
Valley drug trial shows promise in treating deadliest form of brain cancer
  • January 21, 2019
  • Source: ABC15
There's a glimmer of hope in treating the deadliest form of brain cancer, thanks to a drug trial happening right here in the Valley.